Navigation Links
Childhood virus RSV shows promise against adult cancer

SAN ANTONIO (Sept. 6, 2012) RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.

Santanu Bose, Ph.D., of the School of Medicine, is the inventor on a pending U.S. patent of RSV as an oncolytic therapy. This represents a new use for the virus. Bandana Chatterjee, Ph.D., of the School of Medicine and the South Texas Veterans Health Care System, is the co-inventor. Oncolytic viruses preferentially infect and damage cancer cells.

Confirmed in mice

Dr. Bose, associate professor of microbiology and immunology, studied the immune response of normal and cancerous cells to RSV (respiratory syncytial virus). During these studies he discovered RSV's oncolytic properties. Dr. Bose next worked with Dr. Chatterjee, professor of molecular medicine, to test RSV in her mouse model of prostate cancer. Those results again showed a robust anti-cancer effect of RSV.

License agreement

In July, CZ BioMed Corp. of Tampa, Fla., licensed the oncolytic use of RSV in an agreement with South Texas Technology Management (STTM), a regional University of Texas technology-transfer office managed by the Health Science Center. RSV is already showing effectiveness in human trials abroad, according to a company statement.

Dr. Bose, whose work is funded by the National Institutes of Health, said, "This is an exciting development because this is a homegrown invention that is being tested in humans, and therefore this scientific discovery has direct clinical, translational relevance."

"We are pleased that CZ BioMed has agreed to work with us to commercialize Dr. Bose's and Dr. Chatterjee's exciting discovery to efficiently target and treat different forms of cancer," said STTM Executive Director Arjun Sanga, J.D., assistant vice president for technology transfer at the UT Health Science Center.

Advantages to therapy

Dr. Chatterjee said it is important that the virus killed tumors even in mice with competent immune systems. This mirrors human patients who have functioning immune defenses. RSV also worked whether it was injected directly into the tumor or systemically through the abdomen. "This is important because there are some tumors to which you can inject the drug directly, whereas others you can't and a drug must work systemically," Dr. Chatterjee said.

Her work on the RSV project is funded by a Merit-Review grant from the U.S. Department of Veterans Affairs (VA), a VA Senior Research Career Scientist Award, and a grant to Drs. Bose and Chatterjee from the National Cancer Institute.

Normal cells shoot down RSV, cancer cells can't

RSV is expected to be safe because it is a children's virus it does not infect adults. It also only infects the lungs. Dr. Bose explained why RSV grows only in tumors, not healthy cells: "It is because of the immune response. Normal cells have weapons to shoot down viruses, but cancer cells have lost their anti-viral arsenal. For this reason viruses can establish themselves in a tumor, grow and induce cell death."

Results in humans

A press release from CZ BioMed notes: "Ultimately, the results from human trials overseas have been extremely successful and exciting to date, with minimal side effects as compared to traditional chemo or radiation therapies." The company's statement also indicates its plan to conduct a clinical trial with oncolytic RSV in the U.S.

In a series of papers between 2009 and 2011, Drs. Bose, Chatterjee and colleagues advanced the RSV anti-cancer construct. The animal results were particularly exciting mice with prostate tumors were treated with the virus and within a week the tumors were gone. "We kept the mice for four months, and the tumors never came back," Dr. Bose said.


Contact: Will Sansom
University of Texas Health Science Center at San Antonio

Related medicine news :

1. Childhood sexual abuse linked to later heart attacks in men
2. Prenatal exposure to pesticide additive linked with childhood cough
3. Traumatic childhood may increase the risk of drug addiction
4. A breath of fresh air: Childhood Asthma Leadership Coalition launches
5. Radiation for Childhood Cancer Might Raise Diabetes Risk
6. Childhood Music Lessons May Create Better Listeners
7. Doing the math to fight childhood obesity
8. Existing drugs offer new treatment options for high-risk childhood leukemia subtype
9. Childhood Friendships May Be Key to Adult Happiness
10. Childhood defiance correlated with drug dependence
11. In-utero exposure to magnetic fields associated with increased risk of obesity in childhood
Post Your Comments:
Related Image:
Childhood virus RSV shows promise against adult cancer
(Date:10/9/2015)... , ... October 09, 2015 , ... A new health ... Exam Aid, is now available online ( ) – just in time for ... says officially begins in October. However, for many in the U.S., the real start ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... audiologists in The Tennessean's eighth annual Toast of Music City, a reader’s choice ... Nashville residents nominated and cast votes for their favorite businesses in over 200 ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... company, has announced the final product specifications for TRACTUS, the world’s first sterile ... in the United States in response to the FDA’s recent Unique Device Identifier ...
(Date:10/9/2015)... Stockton, CA (PRWEB) , ... October 09, 2015 ... ... year anniversary of their “Agents of Change” program, a community improvement initiative that ... The newest charity to benefit from the assistance of Confidence Plus Insurance is ...
(Date:10/9/2015)... ... 09, 2015 , ... Prescription Hope, the fastest growing pharmacy ... to save money on the high cost of their prescription medications through their ... and families can receive their medications delivered direct from over 180 U.S.-based pharmaceutical ...
Breaking Medicine News(10 mins):
... concern over skin cancer many people still disregard the use of ... was noticed that one in three Briton do not protect ... cases of skin cancer are diagnosed in the UK each year, ... will treble in the next 30 years. ,Research ...
... born in the United States -- more than double the ... for at least 21 serious disorders, according to the ... ,Massachusetts has failed to make progress on expanding the newborn ... District of Columbia require screening for the 29 core, treatable, ...
... shockingly thin during her performance at Hiro Ballroom on July ... about her emaciated appearance. ,The former Hole singer ... shake, then apologized to the crowd, saying that she "had ... Ensure shakes for my anorexia. You're going to have to ...
... make her sex scenes look realistic has landed her with ... recently admitted that she got into a painful problem while ... Steve Buscemi. ,The 25-year-old actress suffered head injuries ... ,"We were making out and I whacked my head really ...
... In a new study, UCLA researchers measured the effect of ... the physical symptoms of the disease and created ... may help clinicians guide treatment. The study appears in the ... revealed that to effectively treat hepatitis B patients, clinicians need ...
... overall cost-effectiveness of Medicare benefits have been much-debated, new ... receiving benefits at age 65 required more intensive ... insured prior to receiving Medicare. These findings, from researchers ... 12 issue of the New England Journal of Medicine. ...
Cached Medicine News:
(Date:10/9/2015)... , Oct. 9, 2015  Xavier University,s Center ... with Konica Minolta Medical Imaging (KMMI) on October 12. ... Thinking to help healthcare providers imagine and develop their ... roadmap that they can customize for their practice. ... is the initial procedure, or study, in medical imaging ...
(Date:10/9/2015)... BETHESDA, Maryland , October 9, 2015 ... Pharmaceuticals Inc. (OTCQB: CNBX) has announced its execution of ... Debt & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, ... the company. --> --> ... internal restructuring of the Company, whereby the Research and ...
(Date:10/9/2015)... MELVILLE, N.Y. , Oct. 9, 2015 ... the world,s largest provider of health care products and ... today reminded its customers that the Henry Schein Disaster ... who experience operational, logistical or financial issues as a ... Carolina . The toll-free number for all ...
Breaking Medicine Technology:
... be showcased at National Health Service EXPOSAN JOSE, Calif., April ... ), a worldwide leader in medical devices for the minimally ... today announced that the UK NHS National Innovation Centre has ... a select innovative technology that is bringing benefits to National ...
... MITI ), a biopharmaceutical company developing novel, ... autoimmune diseases, today announced the filing of the first ... Nycomed for the anti-GM-CSF antibody MT203. Micromet received a ... Nycomed for the achievement of this milestone.Under a 2007 ...
Cached Medicine Technology:
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: